Subscribe for great stories in your community!
King of Prussia-based Center for Breakthrough Medicines, along with its Discovery Labs, has become a symbol for the rapid rise of life sciences in…
A new study prepared by the Chamber of Commerce of Greater Philadelphia found that the number of jobs in the Philadelphia region’s life sciences…
Center for Breakthrough Medicines is partnering with Discovery Labs to speed up its plans to build the capacity to manufacture a substantial number of cell…
The Phila. region recorded the biggest first-quarter increase in venture capital investments among major metro areas in the country this year, writes Noah Zucker…
The Center for Breakthrough Medicines (CBM) has announced a multi-year deal with Achilles Therapeutics in the UK, reports John George for the Philadelphia Business…
The new analytical testing services laboratory opened by the Center for Breakthrough Medicines at the Discovery Labs complex in King of Prussia aims to address…
University of Pennsylvania Professor James Wilson recently signed a five-year renewable deal on behalf of his gene therapy lab to license its manufacturing process…
The Center for Breakthrough Medicines, which is based within MLP Ventures’ Discovery Labs innovation hub campus in King of Prussia, has secured an equity investment…
Despite the pandemic, development of the Center for Breakthrough Medicines in King of Prussia’s Discovery Labs innovation hub is still on track to be…
Brian O’Neill, the King of Prussia real estate mogul known for his outrageous ambition, has decided to step into the cell and gene therapy…
Main Line developer Brian O’Neill is planning to build a $1.1 billion cell and gene therapy manufacturing facility as part of the Discovery…
Before we send you to this site, please subscribe to our daily newsletter.
